THE BURDEN OF ICS/LABA-TREATED ASTHMA PATIENTS IN THE UK ADULT POPULATION

被引：3
|
作者：
Price, D. [1 ]
Mathieson, N. [2 ]
Mulgirigama, A. [2 ]
Scowcroft, A. [2 ]
Pedersini, R. [3 ]
Isherwood, G. [3 ]
Pavord, I. D. [4 ]
机构：
[1] Univ Aberdeen, Acad Ctr Primary Care, Aberdeen, Scotland
[2] Boehringer Ingelheim Ltd UK, Bracknell, Berks, England
[3] Kantar Hlth, Epsom, Surrey, England
[4] Univ Hosp Leicester NHS Trust, Inst Lung Hlth, Glenfield Hosp, Leicester, Leics, England
来源：
THORAX | 2013年 / 68卷
关键词：
D O I：
10.1136/thoraxjnl-2013-204457.167
中图分类号：
R56 [呼吸系及胸部疾病];
学科分类号：
摘要：
引用
收藏
页码：A82 / A82
页数：1
相关论文
共 50 条
  • [41] The add-on effect of tiotropium bromide to ICS/LABA combination inhaler for the patients with severe uncontrolled asthma
    Hojo, Masayuki
    Iikura, Motoyasu
    Sugiyama, Haruhito
    Shirai, Toshihiro
    EUROPEAN RESPIRATORY JOURNAL, 2015, 46
  • [42] Effectiveness of Treatment With Dual Bronchodilation (LABA/LAMA) Compared With Combination Therapy (LABA/ICS) for Patients With COPD: A Population-Based Study
    Monteagudo, Monica
    Nunez, Alexa
    Barrecheguren, Miriam
    Miravitlles, Marc
    ARCHIVOS DE BRONCONEUMOLOGIA, 2022, 58 (10): : 699 - 707
  • [43] The effect of smoking on severity of asthma and quality of life in patients treated with inhaled corticosteroids and long-acting b2-agonist (ICS/LABA)
    Sergeeva, Galina
    Emelyanov, Alexander
    EUROPEAN RESPIRATORY JOURNAL, 2012, 40
  • [44] Population Pharmacokinetic Analysis of Single Inhaler Triple Therapy (ICS/LAMA/LABA) Versus Dual Therapy (LAMA/LABA and ICS/LABA) in Patients with Symptomatic COPD: Combined Results from Three Phase III Trials
    Mehta, R.
    Farrell, C.
    Kilbride, S.
    Zhu, C.
    Brooks, J.
    Barnhart, F.
    Birk, R.
    Lipson, D. A.
    AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2018, 197
  • [45] The comorbidity burden of the treated asthma patient population in British Columbia
    Prosser, R.
    Carleton, B.
    Smith, A.
    CHRONIC DISEASES IN CANADA, 2010, 30 (02) : 46 - 55
  • [46] CAPTAIN: Effects of triple therapy on FEV1 response in patients with inadequately controlled asthma on ICS/LABA
    Kerstjens, Huib A. M.
    Abbott, Carl
    Boulet, Louis-Philippe
    Chang, Sarah
    Chupp, Geoffrey
    Crawford, Jodie
    Hanania, Nicola A.
    Nathan, Robert
    Oppenheimer, John
    Pizzichini, Emilio
    Sagara, Hironori
    Busse, William
    EUROPEAN RESPIRATORY JOURNAL, 2021, 58
  • [47] CAPTAIN: EFFECTS OF BASELINE SABA USE ON RESPONSE TO TRIPLE THERAPY IN PATIENTS WITH INADEQUATELY CONTROLLED ASTHMA ON ICS/LABA
    Busse, William
    Abbott, Carl
    Chang, Sarah
    Casale, Thomas
    Zarankaite, Agne
    Caceres, Diego Maselli
    CHEST, 2021, 160 (04) : 2357A - 2358A
  • [48] Use of ICS/LABA Combinations or LAMA Is Associated with a Lower Risk of Acute Exacerbation in Patients with Coexistent COPD and Asthma
    Su, Vincent Yi-Fong
    Yang, Kuang-Yao
    Yang, Yao-Hsu
    Tsai, Ying-Huang
    Perng, Diahn-Warng
    Su, Wei-Juin
    Chou, Kun-Ta
    Su, Kang-Cheng
    Yen, Yung-Feng
    Chen, Pau-Chung
    JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY-IN PRACTICE, 2018, 6 (06): : 1927 - +
  • [49] Evaluation of inhalant deposition of ICS/LABA in the peripheral airway of asthma patients using Functional Respiratory Imaging (FRI)
    Iwanaga, Takashi
    Kozuka, Takenori
    Nakanishi, Junko
    Yamada, Koji
    Nishiyama, Osamu
    Sano, Hiroyuki
    Murakami, Tamamichi
    Tohda, Yuji
    EUROPEAN RESPIRATORY JOURNAL, 2017, 50
  • [50] SABA and ICS use among mild asthma patients in UK primary care
    Bloom, Chloe
    Quint, Jennifer
    Cabrera, Claudia
    EUROPEAN RESPIRATORY JOURNAL, 2019, 54
12345